Navigation Links
Scientists find protein spurs spread of prostate cancer
Date:5/19/2010

(PHILADELPHIA) Researchers from the Kimmel Cancer Center at Jefferson have found that Stat5, a signaling protein previously found to be key to survival of prostate cancer, is also involved in metastasis.

Their study, published in the online edition of Endocrine-Related Cancer, demonstrates in both laboratory and animal models that nuclear Stat5 over-expression leads to a deadly spread of the cancer. They add that their work with mice was unique in that it was the first time Stat5 was associated with prostate cancer metastasis processes in an animal model.

"Until now, we thought that Stat5 was involved in primarily promoting tumor growth, but this study indicates it could be one of the key players in pushing prostate cancer to spread," said Marja Nevalainen, M.D., Ph.D., associate professor of Cancer Biology, Urology and Medical Oncology at Jefferson Medical College of Thomas Jefferson University. "This seminal paper is sure to open up a new avenue of research, including investigation of therapies that could target Stat5 expression. Fresh approaches are needed since there are no effective therapies for prostate cancer that has metastasized."

This study is just the latest from Dr. Nevalainen's laboratory to show the increasing importance of the Stat5 transcription factor a protein that can regulate expression of other genes. In 2004, she found that nuclear Stat5 is often over-expressed in high-grade human prostate cancer, and in 2005, she demonstrated that Stat5 activity was associated with recurrence of prostate cancer in patients who had already been treated. She then showed in 2008 that nuclear Stat5 was especially prevalent in recurrent prostate cancers that are resistant to hormone therapy. Her research has also demonstrated that blocking Stat5 in laboratory and in animal models effectively destroyed prostate cancer.

"We know that Stat5 is absolutely critical to the survival of prostate cancer cells," she said.

In this study, the researchers found that Stat5 is activated in 61 percent of distant metastases of clinical human prostate cancers. Gene expression profiling indicated that 21 percent of Stat5-regulated genes were related to metastases, 7.9 percent were related to proliferation, and 3.9 percent were linked to cell death.

Digging deeper, they found that active Stat5 expression induced rearrangement of parts of the cytoskeleton of prostate cancer cells and suppressed expression of proteins that bind cells to each other activities that help ready a cell to migrate from a tumor.

Then they made a key finding. When they injected human prostate cancer cells that over-expressed Stat5 into mice, they found that the cancer readily spread to the lungs.

"This result is important because laboratory observations on invasiveness or migration of cells in culture do not necessarily translate into cells having the ability to metastasize in animals," Dr. Nevalainen said. "This work provides the first evidence of the involvement of Stat5 in metastatic progression of human prostate cancer cells in a living system."

The findings need to be replicated in other studies, which are now ongoing. She said they want to use other model systems of metastatic prostate cancer to evaluate whether Stat5 is involved in prostate cancer that spreads to the lymph nodes or to bones.

The normal function of Stat5 is also not yet known, Dr. Nevalainen said.


'/>"/>

Contact: Emily Shafer
emily.shafer@jefferson.edu
215-955-6300
Thomas Jefferson University
Source:Eurekalert

Related medicine news :

1. What to Read on World Ocean Day: Scientists and Non Profits Herald New Eco-Thriller Eye of the Whale
2. Clue to switch of bladder cancer from locally contained to invasive found by Jefferson scientists
3. Wistar scientists explain the persistence of melanoma through dynamic stemness
4. Mass. Eye and Ear receives NEI grant renewal for growing clinical/scientists
5. Scientists Map Neanderthal Genome
6. Genome breakthrough allows scientists to identify and profile tumor cells from very small samples
7. Scientists Unravel Secret of HIV Resistance
8. A century-old puzzle comes together: Scientists ID potential protein trigger in lung disease sarcoidosis
9. President Bill Clinton and South African Health Minister Aaron Motsoaledi to join 25,000 scientists, people living with HIV, and other stakeholders at XVIII International AIDS Conference in Vienna
10. Scientists Find Cause of Involuntary Mirror Movements
11. Scientists Discover Substance That Causes Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, ... ... today, featuring an inspirational interview of two ostomy patients, standing as living proof ... million people suffer from digestive diseases and issues that spike around the holidays. ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet ... in USA Today, which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition ... lives. “We are prolonging life 6 years in the last 3 decades,” says ...
(Date:12/2/2016)... ... 02, 2016 , ... Universal Medical Systems, Inc. (UMS) the ... company to offer robotic imaging to veterinary medicine is sponsoring the appearance of ... the American Association of Equine Practitioners 62nd Annual Convention from December 4-6, 2016 ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Yisrayl Hawkins, at ... into how this current generation fits into Bible Prophecy. Yisrayl says this generation, known ... pointing to this conclusion, showing how the details line up exactly with Bible Prophecy ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)...  PipelineRx, a leading medication management technology company ... of its SaaS-based telepharmacy platform, PowerGridRx™ , ... Midyear Clinical Meeting and Exhibition, December 5-7 in ... 300 hospital clients nationally, the Company is a ... dramatically improve pharmacy operations, enhance patient safety, and ...
(Date:12/2/2016)... 2016  Maxor National Pharmacy Services, LLC ("Maxor"), today announced ... ("PSI").  The combination of Texas -based Maxor ... PSI bring together both company,s clinical expertise and high-touch patient ... industry-leading specialty pharmacy. About Maxor ... , , ...
(Date:12/2/2016)... 2, 2016 Lianluo Smart Limited (Nasdaq: ... Company") which develops, markets and sells medical devices ... China and international markets, recently attended ... Treatment New Progress Forum, co-hosted by the Institute ... , Guangdong Provincial People,s Hospital and Cardiology ...
Breaking Medicine Technology: